Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate major adverse bleeding risks, and thromboembolic
event rates post radiofrequency (RF) ablation. The primary goal is to establish safety of
dabigatran use for peri-procedural anti-coagulation after left atrial catheter radiofrequency
ablation, or cryoablation procedures.
Phase:
Phase 4
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center